Literature DB >> 3080817

General surgery in adult hemophiliacs.

B Brown, D L Steed, M W Webster, M S Makaroun, J A Spero, F A Bontempo, M V Ragni, J H Lewis.   

Abstract

From 1976 to 1984, 23 operations were performed on 22 patients with hemophilia (18 patients with factor VIII and four with factor IX deficiency). Elective procedures included resection of abdominal aortic aneurysm, liver transplantation, vagotomy/pyloroplasty, insertion of Mousseau-Barbin tube, colectomy, cholecystectomy, inguinal herniorrhaphy (four patients), colonoscopy/polypectomy, mediastinoscopy, arteriovenous fistula for dialysis, anal fistulectomy, and miscellaneous skin and soft-tissue procedures (five patients). Emergency operations were appendectomy (two patients), repair of bleeding liver biopsy site, and repair of an incarcerated inguinal hernia. There were two deaths (9%) within 30 days of operation, neither directly caused by the coagulopathy. Four patients had bleeding after surgery, which was treated with additional cryoprecipitate or factor concentrate. There were no nonhemorrhagic complications. Before operation, appropriate replacement therapy with factor VIII concentrate, cryoprecipitate, or fresh-frozen plasma was provided. Coagulation factor levels were measured before operation and monitored daily after operation. Generally, factor levels were raised to at least 1.0 U/ml and maintained at greater than 0.5 U/ml for 7 to 14 days after operation. However, when patients were treated with fresh-frozen plasma, plasma exchange was performed and factor levels of approximately 0.35 U/ml were achieved before surgery. We conclude that operations in patients with hemophilia can be accomplished safely with careful monitoring of coagulation factor levels and appropriate replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080817

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  General surgery in patients with a bleeding diathesis: how we do it.

Authors:  Kamal R Aryal; D Wiseman; Ajith K Siriwardena; Paula H B Bolton-Maggs; Charles R M Hay; James Hill
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Is major surgery in hemophiliac patients safe?

Authors:  W J Rudowski; R Scharf; J M Ziemski
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

3.  Intramural hematoma of the cecum as the lead point of intussusception in an elderly patient with hemophilia A: report of a case.

Authors:  Yoshifumi Nakayama; Masayuki Fukushima; Michio Sakai; Terumasa Hisano; Naoki Nagata; Akira Shirahata; Hideaki Itoh
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Obstructive Ileus caused by blood clot after emergency total gastrectomy in a patient with hemophilia A: report of a case.

Authors:  M Onda; K Urazumi; R Abe; K Matsuo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacs.

Authors:  J L Buehrer; D J Weber; A A Meyer; P R Becherer; W A Rutala; B Wilson; M L Smiley; G C White
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 6.  Massive adrenal vein aneurysm mimicking an adrenal tumor in a patient with hemophilia A: a case report and review of the literature.

Authors:  Richard Sleightholm; Steven Wahlmeier; Jeffrey S Carson; Andjela Drincic; Audrey Lazenby; Jason M Foster
Journal:  J Med Case Rep       Date:  2016-12-01

7.  Totally extraperitoneal inguinal hernia repair in patients with hemophilia and von Willebrand disease. Prospective controlled study.

Authors:  Konrad Pielaciński; Bartosz Puła; Andrzej B Szczepanik
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-02-26       Impact factor: 1.195

8.  Management of a Giant Renal Artery Aneurysm in a Patient with Severe Hemophilia A.

Authors:  Brigita Janicka-Kupra; Arvis Freimanis; Svetlana Rudnicka; Vilnis Lietuvietis; Sandra Lejniece
Journal:  Am J Case Rep       Date:  2022-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.